In-Silico and in Vitro Studies of Picralima nitida Leave Extract as Potential Αlpha-Amylase and Αlpha-Glucosidase Inhibitors
Journal of Chemical Society of Nigeria · 28.04.2026 · 51 (2) · 323-344
DOI: 10.4314/jcsn.v51i2.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Society of Nigeria, online erschienen am 28.04.2026. Verfasst von I E Nnaoma und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Diabetes mellitus, particularly type 2 diabetes, is a growing global health concern characterized by persistently high blood sugar levels due to impaired insulin function. Current synthetic enzyme inhibitors used to manage post-meal glucose spikes often result in gastrointestinal side effects. This study investigated the potential of the n-hexane extract of Picralima nitida as a natural inhibitor of the enzymes α-glucosidase and α-amylase, which are involved in carbohydrate digestion. In silico analyses were conducted using computer-aided drug design (CADD) tools to assess the binding affinities of thirty compounds from the extract against α-glucosidase (PDB: 3TOP) and α-amylase (PDB: 4W93). The in vitro results demonstrated that the extract exhibited moderate yet significant inhibitory activity against both enzymes, suggesting potential antidiabetic effects. Specifically, the extract's highest α-amylase inhibition was 66.97% at a concentration of 10 mg/ml, although this activity slightly decreased at higher concentrations, indicating a non-linear response. In contrast, α-glucosidase inhibition increased with concentration, reaching 64.04% at 100 mg/ml, indicating a dose-dependent effect. In silico findings identified compounds such as 2-methoxy-4-vinylphenol (6.4 and 5.2 kcal/mol), tetrahydroionone (5.7 and 5.5 kcal/mol), and alpha-D-mannofuranoside (5.5 and 5.4 kcal/mol) as strong dual inhibitors, outperforming metformin (5.8 and 4.6 kcal/mol). Additionally, medium-chain fatty acids like lauric and pelargonic acids demonstrated considerable inhibitory potential, while compounds such as ethyl palmitate showed weaker binding. Overall, these results suggest that P. nitida contains promising natural inhibitors that could provide safer alternatives to synthetic medications. Further in vitro and in vivo studies are recommended to validate these findings and support the development of formulations for antidiabetic therapy.
Zitieren
APA
Nnaoma, I. E., Okenwa, I. U., Otuekere, E. I., Ajah, O., & Osiagor, H. C. (2026). In-Silico and in Vitro Studies of Picralima nitida Leave Extract as Potential Αlpha-Amylase and Αlpha-Glucosidase Inhibitors. Journal of Chemical Society of Nigeria, 51(2), 323-344. https://doi.org/10.4314/jcsn.v51i2.10
Vancouver
Nnaoma IE, Okenwa IU, Otuekere EI, Ajah O, Osiagor HC. In-Silico and in Vitro Studies of Picralima nitida Leave Extract as Potential Αlpha-Amylase and Αlpha-Glucosidase Inhibitors. Journal of Chemical Society of Nigeria. 2026;51(2):323-344. doi:10.4314/jcsn.v51i2.10
BibTeX
@article{Nnaoma2026,
author = {Nnaoma, I E and Okenwa, I U and Otuekere, E I and Ajah, O and Osiagor, H C},
title = {In-Silico and in Vitro Studies of Picralima nitida Leave Extract as Potential Αlpha-Amylase and Αlpha-Glucosidase Inhibitors},
journal = {Journal of Chemical Society of Nigeria},
year = {2026},
volume = {51},
number = {2},
pages = {323--344},
doi = {10.4314/jcsn.v51i2.10}
}
EUVIMED